Jörg Köhl mainly investigates Immunology, Immune system, C5a receptor, Receptor and Anaphylatoxin. His Immunology research focuses on Proinflammatory cytokine, Inflammation, Acquired immune system, Complement C5a and Complement system. Jörg Köhl works mostly in the field of Immune system, limiting it down to topics relating to Crosstalk and, in certain cases, Notch Family, Notch proteins, Notch signaling pathway, Interleukin 10 and Jagged-1 Protein.
In his study, which falls under the umbrella issue of C5a receptor, Quantitative trait locus, Gene, Cancer research, Apoptosis and Kidney is strongly linked to Complement factor I. His Receptor study combines topics in areas such as Pharmacology and Transplantation. His Anaphylatoxin research is multidisciplinary, incorporating perspectives in Allergen, Cell biology, Immunopathology and Monocyte.
His primary areas of investigation include Immunology, Immune system, Complement system, C5a receptor and Cell biology. Much of his study explores Immunology relationship to Receptor. His study in Immune system is interdisciplinary in nature, drawing from both Antibody and Cytokine.
The concepts of his Complement system study are interwoven with issues in Sepsis and Effector. His C5a receptor research incorporates elements of Glucocerebrosidase and Complement C5a, Chemotaxis. His studies in Cell biology integrate themes in fields like Secretion and Monocyte.
His primary areas of study are Immunology, Complement system, Immune system, Innate immune system and C5a receptor. His Immunology study is mostly concerned with Inflammation, Autoantibody, Epidermolysis bullosa acquisita, Antibody and Asthma. Jörg Köhl interconnects Complement, Cancer research and Sepsis in the investigation of issues within Complement system.
His Immune system study combines topics from a wide range of disciplines, such as Interleukin 33, Interleukin, Airborne allergen and Lung. His study looks at the intersection of Innate immune system and topics like Effector with Receptor, Lectin pathway, Pathogenesis and Thrombotic microangiopathy. Jörg Köhl focuses mostly in the field of C5a receptor, narrowing it down to topics relating to Alternative complement pathway and, in certain cases, Glucocerebrosidase.
Jörg Köhl focuses on Complement system, Immune system, Immunology, Innate immune system and C5a receptor. His Complement system research includes elements of Non canonical and Complement. His Immunology study frequently intersects with other fields, such as In vitro.
Jörg Köhl usually deals with Innate immune system and limits it to topics linked to Effector and Lectin pathway, Anaphylatoxin, Pathogenesis and Thrombotic microangiopathy. His biological study spans a wide range of topics, including Alternative complement pathway, Epidermolysis bullosa acquisita, Complement factor B and Eculizumab. His Alternative complement pathway study incorporates themes from Glucocerebrosidase, Receptor, Complement membrane attack complex and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The role of the anaphylatoxins in health and disease.
Andreas Klos;Andrea J. Tenner;Kay-Ole Johswich;Rahasson R. Ager.
Molecular Immunology (2009)
CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function
Ian P. Lewkowich;Nancy S. Herman;Kathleen W. Schleifer;Matthew P. Dance.
Journal of Experimental Medicine (2005)
Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
Tom Eirik Mollnes;Ole-Lars Brekke;Michael Fung;Hilde Fure.
Blood (2002)
Functional roles for C5a receptors in sepsis
Daniel Rittirsch;Michael A Flierl;Brian A Nadeau;Danielle E Day.
Nature Medicine (2008)
Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.
Christopher L. Karp;Andrew Grupe;Eric Schadt;Susan L. Ewart.
Nature Immunology (2000)
C3a and C5a Stimulate Chemotaxis of Human Mast Cells
Karin Hartmann;Beate M. Henz;Beate M. Henz;Sabine Krüger-Krasagakes;Sabine Krüger-Krasagakes;Jörg Köhl;Jörg Köhl.
Blood (1997)
Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1
Christian M. Karsten;Manoj K. Pandey;Julia Figge;Regina Kilchenstein.
Nature Medicine (2012)
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.
Sonja Hillebrandt;Sonja Hillebrandt;Hermann E Wasmuth;Ralf Weiskirchen;Claus Hellerbrand.
Nature Genetics (2005)
Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
Oliver Selberg;Hartmut Hecker;Michael Martin;Andreas Klos.
Critical Care Medicine (2000)
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma
Jörg Köhl;Ralf Baelder;Ian P. Lewkowich;Manoj K. Pandey.
Journal of Clinical Investigation (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Lübeck
Johns Hopkins University
University of Lübeck
University of Ulm
University of Pennsylvania
University of Cincinnati
Hannover Medical School
Boston Children's Hospital
Cincinnati Children's Hospital Medical Center
Cincinnati Children's Hospital Medical Center
Karlsruhe Institute of Technology
Concordia University
University of Pittsburgh
Indian Institute of Technology Ropar
Van Andel Institute
Spanish National Research Council
University of Queensland
University of Bayreuth
Institut Pasteur
University of British Columbia
National Aeronautics and Space Administration
Macquarie University
Universidade de São Paulo
University of Chicago
University of East Anglia
University of California, Davis